Bio-Connect

Rabbit anti Human Sphingomyelin Phosphodiesterase 3

Research Use Only
X2359P
Nordic-MUbio
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman
TargetSMPD3
Price on request
100 ug
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Nordic-MUbio
  • Product Name
    Rabbit anti Human Sphingomyelin Phosphodiesterase 3
  • Delivery Days Customer
    7
  • Application Supplier Note
    Antibody can be used for Western blotting (1:400 starting dilution). Optimal concentration should be evaluated by serial dilutions. Protein appears to run lower than expected protein molecular weight. However, antibody is specific for the protein and band blocks when blocking peptide used.
  • Applications
    Western Blot
  • Applications Supplier
    Western Blotting;Western Blotting
  • Category Supplier
    Primary antibodies
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Gene ID55512
  • Target name
    SMPD3
  • Target description
    sphingomyelin phosphodiesterase 3
  • Target synonyms
    neutral sphingomyelinase 2; neutral sphingomyelinase II; NSMASE2; nSMase-2; sphingomyelin phosphodiesterase 3
  • Host
    Rabbit
  • Protein IDQ9NY59
  • Protein Name
    Sphingomyelin phosphodiesterase 3
  • Scientific Description
    nSMase2; Neutral sphingomyelinase 2; EC 3.1.4.12
  • Shelf life instruction
    See expiration date on vial
  • Reactivity
    Human
  • Reactivity Supplier
    Human
  • Reactivity Supplier Note
    Synthetic peptide derived from human sphingomyelin phosphodiesterase 3
  • UNSPSC
    12352203

References

  • 1. Hofmann, K., et al. Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase.; Proc. Natl. Acad. Sci. U.S.A. 97:5895-5900(2000). 2. Miura, Y., et al. Hydrolysis of sphingosylphosphocholine by neutral sphingomyelinases.; FEBS Lett. 557:288-292(2004). 3. Marchesini, N., et al. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.; J. Biol. Chem. 279:25101-25111(2004).